These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 559053)

  • 1. [A case of diphenylhydantoin-induced pseudo-pseudolymphoma (author's transl)].
    Matsuo T; Matsumoto A; Miyasaki K
    Nihon Naika Gakkai Zasshi; 1977 Mar; 66(3):317-21. PubMed ID: 559053
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenytoin-induced pseudolymphoma. A report of a case and review of the literature.
    Harris DW; Ostlere L; Buckley C; Whittaker S; Sweny P; Rustin MH
    Br J Dermatol; 1992 Oct; 127(4):403-6. PubMed ID: 1419762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3 cases of malignant lymphoma or pseudolymphoma in epileptics treated with diphenylhydantoin].
    Alberto P; Cougn R; Maurice P; Weber J
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1773-4. PubMed ID: 5140914
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of primary B-cell origin lymphoma of the stomach seen during diphenylhydantoin therapy (author's transl)].
    Matoba K; Katsumata T; Kakei M; Kuwata H; Nakazawa H; Saigeni K; Okabe H; Chin S; Maekawa K; Katsuoka K; Oh-Ida M; Atari H
    Nihon Shokakibyo Gakkai Zasshi; 1981 Sep; 78(9):1797-802. PubMed ID: 6976466
    [No Abstract]   [Full Text] [Related]  

  • 5. Psuedolymphoma syndrome.
    Halevy S; Feuerman EJ
    Dermatologica; 1977; 155(6):321-7. PubMed ID: 144619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of "exanthematous pseudolymphoma" due to diphenylhydantoin hypersensitivity with a transitory immunologic deficit].
    Vellucci A; Galanti G; Pezzella B; De Longis P; Colacecchi C
    Clin Ter; 1980 Jul; 94(2):229-37. PubMed ID: 7449346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hodgkin's disease following treatment with hydantoins. Report of a case and review of the literature (author's transl)].
    Bladé Creixenti J; Segura Porta F; Nogué Xarau S; Soriano Marín E; García San Miguel J
    Med Clin (Barc); 1980 Jun; 75(1):24-6. PubMed ID: 7392707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced pseudolymphoma with predominantly cutaneous manifestation].
    Sigal M; Pulik M
    Ann Dermatol Venereol; 1993; 120(2):175-80. PubMed ID: 8363313
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of diphenylhydantoin induced lymphadenopathy (author's transl)].
    Ashizawa T; Oda E; Sakuragawa N; Shibata A; Sekiya M; Nemoto K; Okamura A; Ohnishi Y
    Rinsho Ketsueki; 1979 Apr; 20(4):393-9. PubMed ID: 449058
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudolymphoma induced by diphenylhydantoin.
    Gams RA
    J Pediatr; 1970 Dec; 77(6):1100-1. PubMed ID: 5486632
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticonvulsant-induced lymphoma.
    Fried MP; Sunwoo Y
    Laryngoscope; 1975 Oct; 85(10):1770-81. PubMed ID: 1186408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unusual dual hypersensitivity reaction induced by diphenylhydantoin.
    Sisca TS
    Am J Hosp Pharm; 1973 May; 30(5):446-9. PubMed ID: 4267436
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudolymphoma induced by diphenylhydantoin.
    Choovivathanavanich P; Wallace EM; Scaglione PR
    J Pediatr; 1970 Apr; 76(4):621-3. PubMed ID: 5420803
    [No Abstract]   [Full Text] [Related]  

  • 14. [The pseudolymphoma of the stomach(author's transl)].
    Struwe O
    Leber Magen Darm; 1975 Dec; 5(6):249-55. PubMed ID: 1228360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudolymphoma syndrome (author's transl)].
    Stögmann W; Müller W
    Z Kinderheilkd; 1974; 118(1):45-52. PubMed ID: 4139832
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pseudomononucleosis induced by diphenylhydantoin (author's transl)].
    Rodriguez Jornet A; Matías-Guiu J; Coll de Tuero G; Villegas Sánchez G; Sánchez Novials A; Sabriá Leal M
    Med Clin (Barc); 1981 Oct; 77(6):250-2. PubMed ID: 7321640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques.
    Jeng YM; Tien HF; Su IJ
    Epilepsia; 1996 Jan; 37(1):104-7. PubMed ID: 8603615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudolymphoma and lymphoproliferative syndromes in Gougerot-Sjögren syndrome (author's transl)].
    Diebold J; Zittoun R; Tulliez M; Reynes M; Tricot G; Bernadou A; Audouin J
    Sem Hop; 1978 Oct 18-25; 54(33-36):1033-40. PubMed ID: 220714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenytoin-induced pseudolymphoma with mycosis fungoides manifestations.
    Cooke LE; Hardin TC; Hendrickson DJ
    Clin Pharm; 1988 Feb; 7(2):153-7. PubMed ID: 3349752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphadenopathy in phenytoin treatment (author's transl)].
    Seyfeddinipur N
    Dtsch Med Wochenschr; 1976 Oct; 101(40):1454-6. PubMed ID: 823005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.